DUBLIN, IRELAND -- (MARKET WIRE) -- 06/19/2006 -- Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that it has entered into an agreement to make the Uni-Gold Recombigen HIV test available to all Planned Parenthood Federation of America affiliates
